Surface modification of poly (L-lactic acid) microspheres for site-specific delivery of ketoprofen for chronic inflammatory disease

Journal of Drug Targeting

Volumn 21, Issue 3, 2013, Pages 232-239

  Swami, Gaurav ^a   Pooja, Deep ^b   Kulhari, Hitesh ^b   Kymonil, K M ^a   Saraf, S A ^a  

^a BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Gelatin; Ketoprofen; Microspheres; Poly (l lactic acid); Rheumatoid arthritis

Indexed keywords

DICHLOROMETHANE; FIBRONECTIN; GELATIN; KETOPROFEN; MICROSPHERE; POLYLACTIC ACID; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; DRUG TARGETING; ENCAPSULATION; IN VITRO STUDY; MALE; NONHUMAN; OPTICAL DENSITY; PARTICLE SIZE; PAW EDEMA; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY;

EID: 84875928118     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.741137     Document Type: Article

References (28)

1. Carsons S, Lavietes BB, Diamond HS. (1989). Role of fibronectin in rheumatic diseases. In: Mosher DF, ed. Fibronectin. San Diego: Academic Press, 218-232.
2. Chi SC, Jun HW. (1990). Anti-inflammatory activity of ketoprofen gel on carrageenan-induced paw edema in rats. J Pharm Sci, 79, 974-977.
3. Colvin RB. (1989). Fibronectin in wound healing. In: Mosher DF, ed. Fibronectin. San Diego: Academic Press, 201-218.
4. Gandini R, Cunietti E, Pappalepore V, Ferrari M, Deleo B, Locatelli E, Fasoli A, Liverta C. (1983). Effects of intravenous high doses of ketoprofen on blood clotting, bleeding time and platelet aggregation in man. J Int Med Res, 11, 243-246.
5. Groves MJ. (1999). Parenteral drug delivery systems. In: Mathiowitz E, ed. Encyclopedia of Controlled Drug Delivery. Vol 1. New York: John Wiley & Sons, 743-777.
6. Gürol Z, Hekimoglu S, Demirdamar R, Sumnu M. (1996). Percutaneous absorption of ketoprofen. I. In vitro release and percutaneous absorption of ketoprofen from different ointment bases. Pharm Acta Helv, 71, 205-212.
7. Henmi T, Fujii M, Kikuchi K, Yamanobe N, Matsumoto M. (1994). Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base. Chem Pharm Bull, 42, 651-655.
8. Hynes RO. (1990). Fibronectins. New York: Springer-Verlag, 113-145.
9. Jamie M, Sung T, Diane JB. (2001). Preparation and characterization of gelatin surface modified PLGA microspheres. AAPS Pharm Sci, 3, 1-11. DOI: 10.1208/ps030111.
10. Kheradmandnia S, Vasheghani-Farahani E, Nosrati M, Atyabi F. (2010). Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nanomedicine, 6, 753-759.
11. Liang LS, Jackson J, Min W, Risovic V, Wasan KM, Burt HM. (2004). Methotrexate loaded poly(L-lactic acid) microspheres for intraarticular delivery of methotrexate to the joint. J Pharm Sci, 93, 943-956.
12. Lou Y, Olson WP, Tian XX, Klegerman ME, Groves MJ. (1995). Interaction between fibronectin-bearing surfaces and Bacillus Calmette-Guérin (BCG) or gelatin microparticles. J Pharm Pharmacol, 47, 177-181.
13. Noda K, Nakagawa A, Yamagata T, Ide H. (1983). Anti-inflammatory and analgesic gel composition. US Patent, 4, 393, 076.
14. Patil P, Joshi P. (2004). Effect of formulation variable on preparation and evaluation of gelled self-emulsifying drug delivery system of ketoprofen. AAPS Pharm Sci Tech, 3, 42.
15. Perrin DA, English JP. (1997). Polyglycolide and polylactide. In: Domb AJ, Kost J, Wiseman DM, eds. Handbook of Biodegradable Polymers. Amsterdam: Harwood Academic Publishers, 3-25.
16. Podlogar F, Bester Rogac M, Gasperlin M. (2005). The effect of internal structure of selected water-Tween 40-Imwitor 308-IPM microemulsions on ketoprofene release. Int J Pharm, 302, 68-77.
17. Pouton CW. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci, 11 Suppl 2, S93-S98.
18. Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci, 29, 278-287.
19. Ruan G, Feng SS. (2003). Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials, 24, 5037-5044.
20. Scholes PD, Coombes AGA, Davies MC, Illum I, Davis SS. (1997). Particle engineering of biodegradable colloids for site-specific drug delivery. In: Park K, ed. Controlled Drug Delivery: Challenges and Strategies. Washington, DC: American Chemical Society, 73-106.
21. Stolnik S, Dunn SE, Garnett MC, Davies MC, Coombes AG, Taylor DC, Irving MP, Purkiss SC, Tadros TF, Davis SS. (1994). Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)- poly(ethylene glycol) copolymers. Pharm Res, 11, 1800-1808.
22. Streubel A, Siepmann J, Bodmeier R. (2003). Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles. J Microencapsul, 20, 329-347.
23. Tamura T, Imai J, Matsumoto A, Tanimoto M, Suzuki A, Horikiri Y, Suzuki T, Yoshino H, Ike O. (2002). Organ distribution of cisplatin after intraperitoneal administration of cisplatin-loaded microspheres. Eur J Pharm Biopharm, 54, 1-7.
24. Thompson PN, Cho E, Blumenstock FA, Shah DM, Saba TM. (1992). Rebound elevation of fibronectin after tissue injury and ischemia: role of fibronectin synthesis. Am J Physiol, 263, G437-G445.
25. Torchilin VP. (2006). Nanoparticulates as drug carriers. London, Imperial college press, 125-172.
26. Tsung MJ, Burgess DJ. (2001). Preparation and characterization of gelatin surface modified PLGA microspheres. AAPS PharmSci, 3, 14-24.
27. Yaw-Bin H, Ren-Jiunn W, Jui-Sheng C, Yi-Hung T, Pao-Chu W. (2007). Evaluation of ketoprofen formulations via penetration rate and irritation in vivo study. Int J Pharm, 339, 47-51.
28. Yun-Seok R, Jung-Gyo C. (2001). Transdermal delivery of ketoprofen using microemulsions. Int J Pharm, 228, 61-170.